SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (20703)4/16/1999 5:27:00 PM
From: Jacalyn Deaner  Read Replies (1) | Respond to of 23519
 
Get on FOX NEWS now - talking about VVUS and the new viagara competition!!! Good Luck you guys - I had VVUS and wish you longs the best. Jacalyn



To: VLAD who wrote (20703)4/16/1999 5:47:00 PM
From: Zebra 365  Read Replies (3) | Respond to of 23519
 
Vivus Shares Rise After Positive Forecast of 1st-Qtr Earnings

<<Washington, April 16 (Bloomberg) -- Vivus Inc. shares rose as much as 35 percent in trading before the market opened after the company, the developer of an injectible impotence treatment (get it right Bloomberg!), said its earnings would higher than forecast.

Vivus shares rose as much as 1 9/16 to 6 1/16 in trading before U.S. markets opened.

Vivus, which saw sales tumble last year after the introduction of Pfizer Inc.'s blockbuster Viagra, expects to report first-quarter earnings of 12 cents a share, triple the 4- cent forecast of PaineWebber Securities analyst Charles Olsziewski, the only analyst polled by First Call Corp.

The money-losing company said the quarter's results were buoyed by a one-time $4 million payment from drugmaker Astra AB. The payment, which was booked earlier than expected, related to the approval of Vivus' Muse impotence treatment in France

Sweden's Astra AB earlier this month was acquired by Zeneca Group Plc of the U.K. to form AstraZeneca Group Plc, the world's biggest drugmaker.

Vivus had previously expected to report $2 million of that revenue in the first quarter and $2 million in the second quarter, company Chief Executive Leland Wilson said in an interview yesterday.

Wilson said he doesn't expect the full-year results to be different than he has previously indicated. The company will report earnings April 21.>>

BTW a block of 10,000 shares traded after hours at 16:20 for 5 3/4. No other blocks above 1,000 by Quote.com

Zebra


PS: No, this is not a fake Bloomberg article. BTW that extra 2 millon is only 6.7 cents per share, so they were going to make 0.05 per share without it, or breakeven without milestones.



To: VLAD who wrote (20703)4/16/1999 6:19:00 PM
From: 777 Captain  Read Replies (1) | Respond to of 23519
 
IMHO. LW is slowly learning how the game is played. Give the new CFO some credit for being an excellent teacher. Regards.



To: VLAD who wrote (20703)4/17/1999 6:50:00 AM
From: wvalx  Read Replies (1) | Respond to of 23519
 
VLAD, <<Does the VLAD suffer from memory loss or is Mr Wilson playing Bill Gates?>>

Or is this just BAD journalism AGAIN. Remember this little fiasco:
sfgate.com.
Message 8250954

as far as Bloomberg:

"injectible" ha! whatever....who's the a-hole who wrote this article?

I love this little beauty:
"The money-losing company"

Nice objective reporting, THEY'VE BEEN MAKING MONEY OVER THE LAST 2 QUARTERS. They made 1.03 in 1997.

Next quote from article: "The payment, which was booked earlier than expected, related to the approval of Vivus' Muse impotence treatment in France"

what happened to Germany??? (or is that a partial sentence that never got completed, because there isn't even a period at the end.)

As far as this piece of BS: "Wilson said he doesn't expect the full-year results to be different than he has previously indicated."

From the Q4 '98 CC and I F***IN QUOTE:

Richard Walliser: Yeah, Dave, as I commented, we're working here to keep expenses in line with revenues. So we're tailoring that as we go forward. And I think saying anything more than that at this point, I think, would be premature. And also, we are not making projections and have not made projections about future, either revenues and/or profitability going forward.

So if they are not making projections, how could they say that their projections for the year haven't changed!?!?!

Is there a rush to print ANYTHING by these "journalists"? I'd like to get my hands on the tape of the interview, to see what Lee really said.

VLAD, this is why I believe we need one representative for the SI shareholders to get one-on-one access to Leland and Nina. We need facts, the truth!!!